Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Raymond Jiao"'
Autor:
Yuan Feng, Wei Sun, Jie Zhang, Yang Wang, Jinfeng Chen, Xinying Liu, Liang Wang, Shaolei Li, Chao Lv, Fangliang Lu, Jianzhi Zhang, Yang Hong, Shanshan Xiao, Tao Wang, Raymond Jiao, Ziping Wang, Liping Qi, Nan Li, Yue Yang, Dongmei Lin, Jian Fang
Publikováno v:
Thoracic Cancer, Vol 13, Iss 3, Pp 442-452 (2022)
Abstract Background A single‐agent of anti programmed cell death 1/programmed cell death ligand 1 (anti‐PD‐1/PD‐L1) therapy has been explored for resectable lung cancer before surgery. However, the effectiveness and safety of neoadjuvant prog
Externí odkaz:
https://doaj.org/article/fd177f47b56740bca7a3086875335027
Autor:
Yuan Feng, Wei Sun, Jie Zhang, Yang Wang, Jinfeng Chen, Xinying Liu, Liang Wang, Shaolei Li, Chao Lv, Fangliang Lu, Jianzhi Zhang, Yang Hong, Shanshan Xiao, Tao Wang, Raymond Jiao, Ziping Wang, Liping Qi, Nan Li, Yue Yang, Dongmei Lin, Jian Fang
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 13, Iss 3, Pp 442-452 (2022)
Thoracic Cancer, Vol 13, Iss 3, Pp 442-452 (2022)
Background A single‐agent of anti programmed cell death 1/programmed cell death ligand 1 (anti‐PD‐1/PD‐L1) therapy has been explored for resectable lung cancer before surgery. However, the effectiveness and safety of neoadjuvant programmed ce
Autor:
Yuan Feng, Wei Sun, Jie Zhang, Yang Wang, Jinfeng Chen, Xinying Liu, Liang Wang, Shaolei Li, Chao LV, Fangliang Lu, Jianzhi Zhang, Yang Hong, Shanshan Xiao, Tao Wang, Raymond Jiao, Ziping Wang, Liping Qi, Nan Li, Yue Yang, Dongmei Lin, Jian Fang
Background Single agent of PD-1 or PD-L1 inhibitor has been explored recently for resectable patients before surgery. However, the effectiveness and safety of neoadjuvant PD-1 blockade combine with platinum-based doublet chemotherapy has not been ful
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4398bd0874434882ba94cfccd290862
https://doi.org/10.21203/rs.3.rs-23978/v1
https://doi.org/10.21203/rs.3.rs-23978/v1